Opioid misuse and substance use disorders (SUDs) have devastated communities across the country, and a collaborative effort is needed to stem the tide. Through their missions of education, research, and clinical care, the nation’s medical schools and teaching hospitals are actively responding to this public health crisis and preparing the next generation of health care professionals to address the epidemic.
Institutions are actively working with their communities and enhancing content on SUDs and pain management, integrating learning opportunities across the medical education continuum.
The AAMC supports their work by sharing successful practices, approaches, and responses among educators, clinicians, and future physicians. As part of this effort, and in response to ongoing assessments of the needs of the academic medicine community, the AAMC developed a series of strategic activities to further enhance collaboration and sharing of educational practices, including three opportunities intended for educators.
Additional information about the AAMC’s strategic efforts, including the results of a national convening, can be found in the following report: “Responding to the Opioid Epidemic Across the Continuum of Medical Education: Results of a National Action Initiative.”
AAMC Grants/Awards
UC Davis Research Team Commissioned for Competitive Systematic Review Through AAMC/NIDA Partnership
As part of the AAMC’s ongoing efforts to support its members in advancing educational practices in pain management and SUDs, the association partnered with the National Institute on Drug Abuse (NIDA) to commission a systematic literature review of health care professionals’ bias and stigma related to SUDs and the evidence for mitigation efforts.
The results of this systematic review have been published in Academic Medicine: “Stigma Against Patients with Substance Use Disorders Among Health Care Professionals and Trainees and Stigma-Reducing Interventions: A Systematic Review".
A recording of the January 2024 "Looking Inward: Addressing the Stigma of Addiction" webinar is now available. Sign in to watch the video.
AAMC Collaborations
The AAMC collaborates with several organizations to promote and develop curricula and programming. A sample of these collaborations include:
- The Blueprint for Success in the Safe and Appropriate Prescribing of Opioid Analgesics initiative was developed through a strategic collaboration between the AAMC and Medscape Education. This series is designed to familiarize clinicians with the appropriate and safe use of opioid analgesics therapies for pain management. Additional modules will continue to be added to the collection. Continuing medical education credit is available for free after completing each module.
- The AAMC is a founding member of the National Academy of Medicine(NAM) Action Collaborative on Combatting Substance Use and Opioid Crises.
- The Education and Training Work Group of the Action Collaborative developed the 3Cs Framework for Pain and Unhealthy Substance Use: Minimum Core Competencies for Interprofessional Education and Practice to outline the competencies essential for effectively managing pain and addressing issues related to unhealthy substance use in healthcare.
- The AAMC actively collaborates with the Substance Abuse and Mental Health Services Administration (SAMHSA) to engage with medical schools about opioid misuse and SUD education as well as share AAMC resources.
- Coalition on Physician Education in Substance Use Disorders (COPE).
- The new Medical School Addiction Medicine Curriculum Framework includes resources about model curricula, prevention, and training focused on SUDs.
Curricular Examples
Curricular Innovations and Program Development
Over the last five years, several schools and programs have been recognized both for existing exemplary curricula and for the development of new tools and resources towards the advancement of education in addiction and pain management.
Call for Submissions: Opioids, Addiction, and Pain Education Collection
To foster collaboration between educators and their partners to advance pain management, addiction medicine, and opioid education, MedEdPORTAL is seeking submissions for its Opioids, Addiction, and Pain Education Collection. Examples of appropriate resources include checklists, worksheets, lesson plans, cases, and lecture outlines.
Call for Submissions: Integrated Behavioral Health Education
To equip educators and institutions with curricular innovations to increase collaboration with interprofessional behavioral health teams in undergraduate and graduate medical education, MedEdPORTAL is seeking submissions for its Integrated Behavioral Health Education Collection. This peer-reviewed collection emphasizes equitable care for all patients and communities by providing health professions educators with the tools they need to train the next generation to address stigma related to substance use and mental health conditions.
If you have any questions, contact CurricularInnovation@aamc.org.
Other Efforts
White House Challenge to Save Lives from Overdose
The AAMC invites the academic medicine community to join the White House Challenge to Save Lives from Overdose. Medical educators play a unique role in addressing this epidemic and are encouraged to continue their efforts, take new actions, and share their institution’s stories as part of this initiative.
The AAMC has submitted the following commitments:
- Host a national health professions education virtual event on overdose prevention. As a founding member of the Interprofessional Education Collaborative (IPEC), during Overdose Awareness Week 2024, the AAMC will cohost a virtual event focused on teaching health professions students across 22 health professions about the effective use of Naloxone and other overdose prevention interventions and the role of health professionals in preventing overdose deaths.
- Conduct a gap analysis of overdose reversal education in medical school curricula. The AAMC will conduct a gap analysis of overdose reversal strategies included in the curricula at the 158 U.S. MD granting medical schools. In addition, the AAMC will increase the number of medical schools integrating overdose prevention education into their annual White Coat Ceremony to reinforce the humanistic approach to health care.
- Support the integration of overdose prevention education into pathway programs to the health professions. Pathway programs allow students to explore their interests in medicine and other health professions and offer them a chance to develop competencies for becoming successful applicants to health professions programs, plan academic journeys, get clinical exposure, and network. The AAMC will work with pathway program sites to educate enrolled students and alumni on the effective use of Naloxone and other overdose prevention interventions in preventing overdose deaths.
AAMC Data Snapshot: Mapping Substance Use Disorder: 2023 Analysis on Clinically Documented Diagnosis Patterns
This data snapshot uses 2023 billing data from the Clinical Practice Solutions Center to analyze patterns of clinically diagnosed substance use disorders. It highlights disparities in diagnosis by health service line, diagnosis type, payer, and patients’ demographic profiles, and the findings raise questions about access to care, screening practices, and help-seeking behavior.
Regulatory and Policy Updates
Important changes to Drug Enforcement Administration (DEA) license requirements affecting all medical educators
Effective June 27, 2023, all DEA practitioners (except veterinarians) are now required to check a box on their DEA registration application or renewal form indicating that they have satisfied this training requirement. Some practitioners have already satisfied this requirement. Relevant content offered during medical school counts towards this eight-hour requirement. Practitioners who graduated in good standing from a medical (MD or DO granting), dental, physician assistant, or advanced practice nursing school in the United States within five years of June 27, 2023, and successfully completed a comprehensive curriculum that included at least eight hours of training can attest to having met this training requirement without additional action.
This comprehensive curriculum must include the following:
- Treating and managing patients with opioid or other SUDs, including the appropriate clinical use of all drugs approved by the Food and Drug Administration (FDA) for the treatment of a SUD; or
- Safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other SUDs.
Graduates who are unsure if they have met the requirement should reach out to their programs and inquire about the curriculum while they were enrolled. The majority of medical schools include this content in their curriculum.
Medical educators at all U.S. medical schools should:
- Consider reviewing their curricula for the relevant content (listed above) beginning five years ago (June 27, 2018). This does not need to be standalone content and may be integrated throughout the full educational program and experienced in a variety of ways, including simulations, small group discussions, problem-based learning sessions, lectures, clinical rotations, and more.
- As appropriate, prepare a brief statement to share with graduates (June 27, 2018-2023) indicating that the educational program includes a minimum of eight hours of instruction in these relevant areas for treating and managing patients with opioid or other SUDs, including use of FDA approved treatments.
Graduates who fall outside the five-year window or who graduated from a medical school without the required curricular focus can find accredited continuing medical education activities to complete to meet the DEA requirement. You can sort for relevant activities provided at no charge, offered locally, or provided online.
For more information, see the DEA letter written on March 27, 2023.